Prescription drug · ANDA
Pilocarpine Hydrochloride NDC 50268-652
Pilocarpine hydrochloride 5 mg/1 · Tablet, Film coated · Oral · AvPAK
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50268-652-12 | 50268065212 | 20 BLISTER PACK in 1 BOX (50268-652-12) / 1 TABLET, FILM COATED in 1 BLISTER PACK (50268-652-11)Marketed from Jan 7, 2021 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Pilocarpine Hydrochloride
- Generic name (nonproprietary)
- pilocarpine hydrochloride
- Active ingredients
- Pilocarpine hydrochloride — 5 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- AvPAK
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 077220
- Marketing start
- Listing expires
- Other FDA classes
- Cholinergic Agonists (Mechanism)Cholinergic Muscarinic Agonists (Mechanism)
- Identifiers
- Product ID 50268-652_47fb4499-fabd-6354-e063-6394a90a8c41SPL ID 47fb4499-fabd-6354-e063-6394a90a8c41SPL set ID b85547d8-fcec-323d-e053-2995a90a4e7eRxCUI 1000913UNII 0WW6D218XJ
- Pharmacologic class
- Cholinergic Receptor Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N450268065212followed by a unit qualifier and the quantityPackage 50268-0652-12. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE: Pilocarpine hydrochloride tablets, USP are indicated for 1) the treatment of symptoms of dry mouth from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck; and 2) the treatment of symptoms of dry mouth in patients with Sjogren's syndrome.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 077220
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Pilocarpine Hydrochloride | Pilocarpine hydrochloride 7.5 mg/1 | Tablet, Film coatedOral | Lannett Company, Inc. | 0527-1407 |
| Pilocarpine Hydrochloride | Pilocarpine hydrochloride 5 mg/1 | Tablet, Film coatedOral | Lannett Company, Inc. | 0527-1313 |
| Pilocarpine Hydrochloride | Pilocarpine hydrochloride 5 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 72162-1078 |
| Pilocarpine Hydrochloride | Pilocarpine hydrochloride 5 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 63629-2099 |
| Pilocarpine Hydrochloride | Pilocarpine hydrochloride 5 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 63629-8351 |